Modernizing IP Management in Pharmacy Operations

This article is a guide on modernizing IP management and outlines the significant role pharmacies play in ensuring data integrity and compliance within clinical trials. It discusses the recent revision of ICH E6 to ICH E6 (R3), which introduces a modernized framework for investigational product management. The guide explains how the new guidelines affect pharmacy operations, emphasizing the importance of adopting risk-based approaches to product management, improving documentation, and enhancing digital traceability. It details the shift from traditional compliance to risk-based quality management, highlighting the need for pharmacies to tailor their controls and documentation according to the complexity of clinical trials. The article also covers the move towards decentralized trial models, enabling more flexible and efficient distribution of investigational products. By adapting to these new standards, pharmacies can ensure patient safety while maintaining compliance and data integrity in clinical research.